In all fairness, Joe doesn’t refer to these types of financings as great deals. Generex is stuck and he’s trying to get the company unstuck. He says these are the types of deals he’s trying to avoid by working towards an uplisting. Generex isn’t there, yet they’re integrated telemedicine into the company and pushing DME-IQ. That probably requires internal investment.